SE7412058L - - Google Patents

Info

Publication number: SE7412058L
Authority: SE; Sweden
Prior art keywords: alpha; beta; pregnen; methylen; diones
Prior art date: 1973-09-26

Application number

SE7412058A

Other languages

Unknown language ( )

English (en)

Inventor

U Kerb

R Wiechert

L Alig

A Furst

M Muller

P Keller

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1973-09-26

Filing date

1974-09-25

Publication date

1975-03-27

1974-09-25 Application filed by Schering Ag filed Critical Schering Ag

1975-03-27 Publication of SE7412058L publication Critical patent/SE7412058L/

Links

230000001072 progestational effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Epoxy Compounds (AREA)

SE7412058A 1973-09-26 1974-09-25 SE7412058L (it)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19732349024 DE2349024A1 (de)	1973-09-26	1973-09-26	6beta,7beta-epoxy-1alpha,2alphamethylen-d-homo-4-pregnen-3,20-dione

Publications (1)

Publication Number	Publication Date
SE7412058L true SE7412058L (it)	1975-03-27

Family

ID=5894080

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE7412058A SE7412058L (it)	1973-09-26	1974-09-25

Country Status (16)

Country	Link
US (1)	US3965128A (it)
JP (1)	JPS5059362A (it)
AR (1)	AR202946A1 (it)
AU (1)	AU7374074A (it)
BE (1)	BE820381A (it)
DD (1)	DD114599A5 (it)
DE (1)	DE2349024A1 (it)
DK (1)	DK507974A (it)
FI (1)	FI280574A7 (it)
FR (1)	FR2244492A1 (it)
IL (1)	IL45629A0 (it)
LU (1)	LU70985A1 (it)
NL (1)	NL7412747A (it)
NO (1)	NO743449L (it)
SE (1)	SE7412058L (it)
ZA (1)	ZA746131B (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6022890A (en) *	1997-11-14	2000-02-08	Merck & Co., Inc.	Immunosuppressant tetracyclic triterpenes
AU1399199A (en) *	1997-11-14	1999-06-07	Merck & Co., Inc.	Immunosuppressant tetracyclic triterpenes
CA2584507C (en)	2004-10-20	2016-04-26	Resverlogix Corp.	Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
EP2314295B1 (en) *	2005-07-29	2015-01-28	Resverlogix, Inc	Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
CA2676984C (en)	2007-02-01	2015-03-17	Resverlogix Corp.	Compounds for the prevention and treatment of cardiovascular diseases
CA2711103C (en)	2008-06-26	2016-08-09	Resverlogix Corp.	Methods of preparing quinazolinone derivatives
AU2010204106B2 (en)	2009-01-08	2014-05-08	Resverlogix Corp.	Compounds for the prevention and treatment of cardiovascular disease
WO2010106436A2 (en)	2009-03-18	2010-09-23	Resverlogix Corp.	Novel anti-inflammatory agents
AU2010239266B2 (en)	2009-04-22	2015-01-22	Resverlogix Corp.	Novel anti-inflammatory agents
CA2851996C (en)	2011-11-01	2020-01-07	Resverlogix Corp.	Pharmaceutical compositions for substituted quinazolinones
WO2014080291A2 (en)	2012-11-21	2014-05-30	Rvx Therapeutics Inc.	Biaryl derivatives as bromodomain inhibitors
WO2014080290A2 (en)	2012-11-21	2014-05-30	Rvx Therapeutics Inc.	Cyclic amines as bromodomain inhibitors
US9271978B2 (en)	2012-12-21	2016-03-01	Zenith Epigenetics Corp.	Heterocyclic compounds as bromodomain inhibitors
WO2016147053A1 (en)	2015-03-13	2016-09-22	Resverlogix Corp.	Compositions and therapeutic methods for the treatment of complement-associated diseases

1973
- 1973-09-26 DE DE19732349024 patent/DE2349024A1/de active Pending
1974
- 1974-09-10 IL IL45629A patent/IL45629A0/xx unknown
- 1974-09-23 US US05/508,492 patent/US3965128A/en not_active Expired - Lifetime
- 1974-09-24 DD DD181291A patent/DD114599A5/xx unknown
- 1974-09-24 LU LU70985A patent/LU70985A1/xx unknown
- 1974-09-25 NO NO743449A patent/NO743449L/no unknown
- 1974-09-25 JP JP49110412A patent/JPS5059362A/ja active Pending
- 1974-09-25 SE SE7412058A patent/SE7412058L/ not_active Application Discontinuation
- 1974-09-26 ZA ZA00746131A patent/ZA746131B/xx unknown
- 1974-09-26 FI FI2805/74A patent/FI280574A7/fi unknown
- 1974-09-26 NL NL7412747A patent/NL7412747A/xx unknown
- 1974-09-26 AR AR255786A patent/AR202946A1/es active
- 1974-09-26 FR FR7432429A patent/FR2244492A1/fr not_active Withdrawn
- 1974-09-26 BE BE148933A patent/BE820381A/xx unknown
- 1974-09-26 DK DK507974A patent/DK507974A/da unknown
- 1974-09-26 AU AU73740/74A patent/AU7374074A/en not_active Expired

Also Published As

Publication number	Publication date
AU7374074A (en)	1976-04-01
FR2244492A1 (it)	1975-04-18
FI280574A7 (it)	1975-03-27
BE820381A (fr)	1975-03-26
DD114599A5 (it)	1975-08-12
NO743449L (it)	1975-04-28
DK507974A (it)	1975-06-09
LU70985A1 (it)	1975-03-06
DE2349024A1 (de)	1975-04-10
JPS5059362A (it)	1975-05-22
AR202946A1 (es)	1975-07-31
US3965128A (en)	1976-06-22
IL45629A0 (en)	1974-11-29
NL7412747A (nl)	1975-04-01
ZA746131B (en)	1975-09-24

Similar Documents

Publication	Publication Date	Title
SE7412058L (it)	1975-03-27
CA1030951A (en)	1978-05-09	1,3-OXYGENATED 8.alpha.-OESTRATRIENES
CA1030950A (en)	1978-05-09	1,3-OXYGENATED 8.alpha.-OESTRATRIENES
CA1034572A (en)	1978-07-11	6-NOR-6-ALKYL-9,10-DIHYDRO-2'.beta.-METHYL-5'.alpha.-BENZYL-ERGOPEPTINE
CA1033716A (en)	1978-06-27	17.beta.-HYDROXY-16,16-DIMETHYLESTR-4-EN-3-ONE
ZA717774B (en)	1972-08-30	New 6alpha-fluoro-16alpha,18-dimethyl-delta 1,4-pregnadiene-3,20-diones
CA942295A (en)	1974-02-19	PROCESS FOR THE MANUFACTURE OF PREGNAN-20-ONE-3.beta.,5.beta.,14.beta.,21-TETROL
CA913613A (en)	1972-10-31	11,21-BIS-OXYGENATED-17.alpha.-HYDROXY-16.beta.-METHYL-STEROID-3,20-DIONES
CA857868A (en)	1970-12-08	17-HYDROXY- AND 17-ACYLOXY-6.beta.,7.beta.-EPOXY-1.alpha.,2.alpha.-METHYLENE-4-PREGNENE-3,20-DIONES
IL38241A0 (en)	1972-01-27	New 6alpha,16alpha-dimethyl-diketo pregnanes
CA857869A (en)	1970-12-08	6.alpha.,16.beta.-DIMETHYL-11-OXYGENATED-4-PREGNENE-17.alpha.,21-DIOL-3,20-DIONES
CA893110A (en)	1972-02-15	3,20-DIOXO 16.alpha.,17.alpha.-DIHYDROXY 19-NOR PREGNA-4-ENE
CA851179A (en)	1970-09-08	17.alpha.-ACYLOXY-6.alpha.-METHYL-16-METHYLENEPREGN-4-ENE-3,20-DIONES
CA1015744A (en)	1977-08-16	15.alpha. - SULFONYLOXY - 12.beta. - HYDROXYPREGNANES AND PROCESS FOR THE PREPARATION THEREOF
CA843408A (en)	1970-06-02	1,4-pregnadiene from biological dehydrogenation
CA972350A (en)	1975-08-05	1,2-METHYLENE-17.alpha.-ACYLOXY(OR IMPROVED HYDROXY)-9.beta.,10.alpha.-STEROID COMPOUNDS OF THE PREGNANE SERIES, PHARMACEUTIC PREPARATIONS OF THE BASIS OF THE NOVEL COMPOUNDS AND METHODS OF PRODUCING SAID COMPOUNDS AND PREPARATIONS
CA850657A (en)	1970-09-01	2,3-dihydro-1,4-benzoxazines
CA861501A (en)	1971-01-19	6-METHYL-9.beta., 11.beta.-OXIDO-16.alpha.,17.alpha.-21-TRIHYDROXY STEROIDS
CA866780A (en)	1971-03-23	9.beta.,10.alpha. STEROIDS
CA895285A (en)	1972-03-14	1.alpha.,2.alpha.;6.beta.,7.beta.-DIMETHYLENE STEROIDS
CA858561A (en)	1970-12-15	2,4-DIBROMOPREGNANE-17.alpha.,21-DIOL-3,11,20-TRIONE-21-ACYLATE
CA839251A (en)	1970-04-14	4-OXA-9.beta.,10.alpha.-STEROIDS
CA866779A (en)	1971-03-23	9.beta.,10.alpha.-STEROID
CA882103A (en)	1971-09-28	11.beta.-HYDROXY-5.alpha.,6.alpha.-EPOXYSTEROIDE
NZ182865A (en)	1979-06-08	2.9 -dichloro-6 -fluoro-16 -methyl-11 ,17 , 21-trihydroxy-pregna-1,4-diene-3,20-diones

Legal Events

Date

Code

Title

Description

1995-02-28

NAV

Patent application has lapsed

Ref document number: 7412058-5

Format of ref document f/p: F